
Investments
Top 1% Biotech 89bio Scores 25% Gain As Battle In Liver Disease Heats Up
Small biotech company 89bio (ETNB) scored a win Wednesday in fatty liver disease, and ETNB stock rocketed well above its 50-day moving average The company tested a drug called pegozafermin in patients with nonalcoholic steatohepatitis, […]